Original Research
Accepted on 15 May 2026
Real-world study of efgartigimod in AChR antibody-positive generalized myasthenia gravis: thymus status, multi-domain symptom improvement and steroid-sparing effect
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders